There’s Nothing Generic About Teva Pharmaceutical Industries Ltd.’s 11% Drop in February – Motley Fool


Motley Fool
There’s Nothing Generic About Teva Pharmaceutical Industries Ltd.’s 11% Drop in February
Motley Fool
What: Shares of Teva Pharmaceutical Industries (NYSE:TEVA), a developer of innovative and generic therapies, sank 11% in February, based on data from S&P Global Market Intelligence. The reason for the drop can be found in the company’s fourth-quarter …
Teva Pharmaceutical Industries Ltd (ADR) Receives Conditional EU Approval for Allergan Plc DealBidness ETC
Teva Pharmaceutical Industries Gains as EC Gives Greenlight to Purchase of Allergan’s Global Generics Assets (NYSE Sonoran Weekly Review
Report: Teva to win EU green light for Allergan dealSeeking Alpha

all 85 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd